V. Pierrat, L. Marchand-martin, and C. Arnaud, Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study, BMJ, vol.358, p.3448, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01610207

T. Moore, E. M. Hennessy, and J. Myles, Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies, BMJ, vol.345, p.7961, 2012.

P. Ancel and F. Goffinet, EPIPAGE-2 Writing Group et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study, JAMA Pediatr, vol.169, issue.3, pp.230-238, 2015.

K. Lui, M. Abdel-latif, and C. Allgood, Improved outcomes of extremely premature outborn infants: Effects of strategic changes in perinatal and retrieval services, Pediatrics, vol.118, pp.2076-83, 2006.

V. Pierrat, A. Coquelin, and M. Cuttini, Translating Neurodevelopmental Care Policies Into Practice: The Experience of Neonatal ICUs in France-The EPIPAGE-2 Cohort Study. Pediatr Crit Care Med, vol.17, pp.957-67, 2016.

P. Ancel, S. Marret, and B. Larroque, Are maternal hypertension and small-forgestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study, Am J Obstet Gynecol, vol.193, issue.1, pp.178-84, 2005.

A. H. Jobe, The new bronchopulmonary dysplasia, Curr Opin Pediatr, vol.23, issue.2, pp.167-72, 2011.

E. S. Twilhaar, R. M. Wade, and J. F. De-kieviet, Cognitive Outcomes of Children Born Extremely or Very Preterm Since the 1990s and Associated Risk Factors: A Metaanalysis and Meta-regression, JAMA Pediatr, vol.172, issue.4, pp.361-368, 2018.

R. J. Palisano, P. Rosenbaum, and D. Bartlett, Content validity of the expanded and revised Gross Motor Function Classification System, Dev Med Child Neurol, 2008.

E. A. Sand and C. Emery-hauzeur,

, Acta Neurol Psychiatr Belg, vol.62, pp.1087-102, 1962.

, Courbes de morphométrie standard, 2020.

A. H. Jobe, E. Bancalari, and . Bronchopulmonary, Am J Respir Crit Care Med, vol.163, issue.7, pp.1723-1732, 2001.

F. Serenius, K. Källén, and M. Blennow, Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden, JAMA, vol.309, issue.17, pp.1810-1830, 2013.

K. Källén, F. Serenius, and M. Westgren, Impact of obstetric factors on outcome of extremely preterm births in Sweden: prospective population-based observational study (EXPRESS), Acta Obstet Gynecol Scand, vol.94, issue.11, pp.1203-1217, 2015.

G. L. Malin, R. K. Morris, and K. S. Khan, Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis, BMJ, vol.340, p.1471, 2010.

E. M. Janz-robinson, N. Badawi, and K. Walker, Neurodevelopmental Outcomes of Premature Infants Treated for Patent Ductus Arteriosus: A Population-Based Cohort Study, J Pediatr, vol.167, issue.5, pp.1025-1032, 2015.

E. J. Short, N. K. Klein, and B. A. Lewis, Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes, Pediatrics, vol.112, issue.5, p.359, 2003.

Y. W. Wu and J. M. Colford, Chorioamnionitis as a risk factor for cerebral palsy, JAMA, vol.284, issue.11, pp.1417-1441, 2000.

A. Pappas, D. E. Kendrick, and S. Shankaran, Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates, JAMA Pediatr, 2014.

, Feb, vol.168, issue.2, pp.137-184

Y. Sasaki, K. Ishikawa, and A. Yokoi, Short-and long-term outcomes of extremely preterm infants in Japan according to outborn/inborn birth status. Pediatr Crit Care Med, vol.20, pp.963-972, 2019.

R. Vliegenthart, A. H. Van-kaam, and A. Csh, Duration of mechanical ventilation and neurodevelopment in preterm infants, Arch Dis Child Fetal Neonatal Ed, vol.104, issue.6, pp.631-636, 2019.

A. Fily, Factors Associated With Neurodevelopmental Outcome at 2 Years After Very Preterm Birth: The Population-Based Nord-Pas-de-Calais EPIPAGE Cohort, Pediatrics, vol.117, issue.2, pp.357-66, 2006.

T. F. Yeh, Y. J. Lin, and H. C. Lin, Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity, N Engl J Med, vol.350, issue.13, pp.1304-1317, 2004.

B. P. Murphy, T. E. Inder, and P. S. Huppi, Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease, Pediatrics, vol.107, issue.2, pp.217-238, 2001.

P. Jarreau, M. Fayon, and O. Baud, Utilisation de la corticothérapie postnatale chez le nouveau-né prématuré dans la prévention et le traitement de la dysplasie bronchopulmonaire : état des lieux et conduite à tenir, 2010.

O. Baud, L. Maury, and F. Lebail, Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial, Lancet, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01278609

O. Baud, C. Trousson, and V. Biran, Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth. Arch Dis Child Fetal Neonatal Ed, vol.104, pp.30-35, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02538991

K. L. Watterberg, M. L. Shaffer, and M. J. Mishefske, Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants, Pediatrics, vol.120, issue.1, pp.40-48, 2007.

O. M. Peltoniemi, A. Lano, and R. Puosi, Trial of early neonatal hydrocortisone: two-year follow-up, Neonatology, vol.95, issue.3, pp.240-247, 2009.

N. A. Parikh, K. A. Kennedy, and R. E. Lasky, Neurodevelopmental Outcomes of Extremely Preterm Infants Randomized to Stress Dose Hydrocortisone, PLoS One, vol.10, issue.9, p.137051, 2015.

, Birth weight (median, grams), vol.770

. Intra-uterine,

, Oxygenotherapy ( median, days), vol.80, pp.65-97